NCT00684190View on ClinicalTrials.gov

Drug Interaction Study Between AZD3355 and Nexium

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

AZD3355

150 mg bid, oral, 7 days

DRUG

Esomeprazole

40 mg od, oral, 7 days

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY